Follow the AlzeCure Pharma AB share price and the full directors' dealings record of the company, a listed issuer based in Finland. Shares trade on the FI market, under the supervision of FIN-FSA. Operating in the Health Care sector, AlzeCure Pharma AB has logged 10 reports. Market capitalisation: €798.2m. The latest transaction was filed on 4 July 2026 (Purchase). Among the most active insiders: Martin Jönsson. All data is free.
10
Insider Decl.
n/a
Thresholds
€303,442
10 ops.
Buy Volume
n/a
n/a
Sell Volume
47Σ signal
Buys €303,442n/a Sells
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
20,000 shares@ SEK 8.97100.0% of flowAktieISINISIN SE0010133785FI:A001P627-1
10 of 10 declarations
About AlzeCure Pharma AB
AlzeCure Pharma AB is a biopharmaceutical company focused on developing treatments for neurodegenerative diseases, particularly Alzheimer's disease. It is listed on the XSTO market.